RE:Line up Mr. Nicolas again! I'd agree. The dataset will be small. It's likely going to be hard to draw firm conclusions. I think colour adds a lot in those circumstances.
Wino115 wrote: Ok, looks like we need another talking head engagement with mass media! Who's up for it? /s
I recall some small Canadian firm once also presented it as their "best idea". We need to line up folks for one a week for next 8 weeks to keep that 4-handle! On a serious note, I think it would behoove management as they engage with the investigators on Phase 1a that, if warranted, they request they provide some context around whatever results they see.
Luckily they have one of the top oncology clinics leading the trial and I've compared their enrolled clinical trials to some others and they are multiples ahead in how many they offer (I guess given the size of the staff). So they are perfect doctors to compare and contrast TH1902 at this point versus their previous experiences. I hope they get Dr. Meric-Bernstam in that PR so whomever is looking at investing and reading on the data can understand it better - regardless if it's just safety and MTD or all that plus a bit of POC or efficacy tidbits. They need to move the program understanding to another level once that hard data is available.